ARCHIVES

Satraplatin Improved PFS In Refractory Prostate Cancer

This article is from The Cancer Letter archive.

Vol. 26 No. 7 | July 25, 2003

Download PDF Visit The Full Archive

Related Articles

ACS Urged To Put More Resources Into Psychosocial Research

May 8, 1981

In Brief: “Massive Reassessment” Of Centers Going On, Tim Talbot Believes; WHO Drops ICRB Service

December 9, 1977

Avastin-Zybrestat Combination Increases Progression-Free Survival in Phase II Trial

March 28, 2014

HHS Carcinogen Guidelines Draft

June 13, 1980

Implants Don’t Cause Cancer, Long-Term Study Finds

May 26, 2006

Avon Awards $16.2 Million To Cancer Centers, Others.

April 6, 2001